TSS
BNTC icon

Two Sigma Securities’s Benitec Biopharma BNTC Stock Holding History

Two Sigma Securities’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,240
Closed -$9.36K – 2680
2022
Q4 		$9.36K Buy
+3,240
New +$11K ﹤0.01% 2372
2022
Q3 		– Sell
-1,428
Closed -$28K – 2620
2022
Q2 		$28K Buy
+1,428
New +$33.2K ﹤0.01% 1919

Other funds holding BNTC

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Two Sigma Securities's BNTC Position: Q1 2023 in Review

Two Sigma Securities sold out of Benitec Biopharma (BNTC) in Q1 2023, closing a stake of 3,240 shares — an estimated $9.36K sold.

Two Sigma Securities first reported a position in BNTC in Q2 2022 and held it in 2 quarters. The position peaked at $28K in Q2 2022. 21 funds tracked by Wall St. Rank hold BNTC as of Q1 2023.

  • Two Sigma Securities reported no remaining Benitec Biopharma position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 3,240 Benitec Biopharma shares in Q1 2023, an estimated $9.36K.
  • Two Sigma Securities first reported a position in Benitec Biopharma in Q2 2022 and held it in 2 quarters.
  • Two Sigma Securities's Benitec Biopharma position peaked at $28K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.